在头部和部癌症中新辅助免疫疗法和化学免疫疗法方案:系统性审查和元分析

Hannah Q Baratz1, Cecelia Hidalgo1, Daniel L Price1

  • 1Department of Otolaryngology-Head and Neck Surgery, Mayo Clinic, Rochester, Minnesota.

概括

与单独免疫疗法相比,新辅助化疗免疫疗法显著改善了头部和部状细胞癌 (HNSCC) 的病理反应率. 进一步的第三阶段试验是有必要的,以直接比较这些新辅助疗法.

相关概念视频

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.0K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K